2002, Lyman M. Stowe Award, University of Connecticut
2001, Sylvia Bodak Memorial Scholarship Award, University of Connecticut
2000-2002, Hellenic Medical Society of New York Award and Scholarship
1998-2002, University of Connecticut Health Center Auxiliary Award
Wallis E, Evageliou N. Neuroblastoma. In: Florin T, Ludwig S, editors. Netter's pediatrics. Philadelphia: Saunders Elsevier; 2011.
2006-present, Children's Oncology Group
2006-present, American Society of Hematology
2006-present, American Society of Pediatric Hematology and Oncology
2006-present, American Association for Cancer Research
Evageliou N, Michael Hogarty. Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma. Clin Cancer Res. 2009 Oct 1;15(19):5956-61. Read the article
Evageliou N. A phase I of DFMO (D,L-difluoromethylornithine) in combination with ironotecan and temozolamide in patients with relapsed and refractory high-risk neuroblastoma [presentation]. AACR/ASCO Vail Methods in Clinical Cancer Research Workshop; 2009 Aug; Vail, CO.
Evageliou N. Dual targeting of AMD1 and ODC1 potently inhibits neuroblastoma initiation in vitro and in vivo [presentation]. American Association for Cancer Research; 2009 Apr; Denver, CO.
Evageliou N. Dual targeting of AMD1 and ODC1 potently inhibits neuroblastoma initiation in vitro and in vivo [presentation]. American Society of Pediatric Hematology and Oncology (ASPHO); 2009 Apr; San Diego, CA.« Back to Previous Page